Review: In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment

Rozalina McCoy, Steven Smith

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)JC2
JournalAnnals of internal medicine
Volume161
Issue number4
DOIs
StatePublished - Aug 19 2014

ASJC Scopus subject areas

  • Internal Medicine

Cite this